StocksMedium•6 November 2026•
1 min read
Humana Raises Full-Year 2026 Profit Forecast on Lower Medical Costs
Key Facts
1Humana raised its full-year 2026 adjusted earnings per share guidance following its Q3 results.
2The guidance hike is primarily driven by lower-than-anticipated medical costs.
Humana raised its full-year 2026 adjusted earnings per share guidance following its third-quarter results. According to investing.com, the guidance hike is primarily driven by lower-than-anticipated medical costs, allowing for a more optimistic bottom-line forecast for the remainder of the fiscal year.
Humana closed at $411.79 on November 5, 2026, with the stock trading between a day low of $405.4 and a high of $423.97 during that session. The increased outlook reflects operational efficiency and improved margins resulting from favorable medical cost ratios observed during the third quarter.